{
    "2021-12-07": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Here is What Hedge Funds Think About Eli Lilly and Company (LLY)",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Eli Lilly",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "10 Pharmaceutical Stocks to Buy According to Brandon Haleyâ€™s Holocene Advisors",
                "features": {
                    "keywords": [
                        "Pharmaceutical Stocks",
                        "Buy",
                        "Brandon Haley",
                        "Holocene Advisors"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Biohaven (BHVN) Intranasal Migraine Therapy Meets Goal in Study",
                "features": {
                    "keywords": [
                        "Biohaven",
                        "BHVN",
                        "Intranasal Migraine",
                        "Therapy",
                        "Goal",
                        "Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Roche (RHHBY) Actemra Gets CHMP Recommendation for COVID-19",
                "features": {
                    "keywords": [
                        "Roche",
                        "RHHBY",
                        "Actemra",
                        "CHMP",
                        "Recommendation",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}